Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.
about
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposureIs Fluconazole or an Echinocandin the Agent of Choice for Candidemia.Candida glabrata--unique features and challenges in the clinical management of invasive infections.Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience.What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.Survival in Patients with Candida glabrata Bloodstream Infections is Associated with Fluconazole Dose.Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score AnalysisCandida glabratafungaemia at an Australian cancer centre: epidemiology, risk factors and therapy
P2860
Q30235457-71DC7AEC-0402-4D5B-9868-194DC6B36A33Q33622743-CB54AD21-D00E-4B2C-9C90-8CAF1248A83AQ36933437-8A734874-932B-4D5F-B470-99D4E67E9C8AQ37036603-5476101C-FE73-4B40-B5AF-B756225D76DFQ38535647-227A9829-0A4A-48DF-9427-62AF2B62B6E8Q38553440-4045ECAE-1D90-4E74-A7E7-AEFE09FE4928Q40184271-75AD5277-813B-4331-A93B-C9E1174D7283Q44075614-6E9AE3F4-F3C0-4B30-BE77-77585C996456Q47749829-C0556A70-FFA9-47C2-8D93-4E788EE26143Q54247940-588D3136-6F9E-4218-9D12-064FCBB777E2Q54957028-3CA2D1C6-249B-4281-887A-8854D3DC4162Q56794081-BFF2308C-0F69-41F3-ADC1-E19C4B0D5E9EQ57746053-5DFEA368-31F3-4AE6-9253-E1C57AEA3DA9
P2860
Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Fluconazole versus an echinoca ...... a retrospective cohort study.
@ast
Fluconazole versus an echinoca ...... a retrospective cohort study.
@en
type
label
Fluconazole versus an echinoca ...... a retrospective cohort study.
@ast
Fluconazole versus an echinoca ...... a retrospective cohort study.
@en
prefLabel
Fluconazole versus an echinoca ...... a retrospective cohort study.
@ast
Fluconazole versus an echinoca ...... a retrospective cohort study.
@en
P2093
P2860
P356
P1476
Fluconazole versus an echinoca ...... a retrospective cohort study.
@en
P2093
Brian A Potoski
Cornelius J Clancy
Gregory A Eschenauer
Kenneth P Klinker
Minh-Hong Nguyen
Peggy L Carver
Ryan K Shields
Shu-Wen Lin
Simon W Lam
Yee-Chun Chen
P2860
P304
P356
10.1093/JAC/DKS482
P407
P577
2012-12-04T00:00:00Z